News for Gilead Sciences, Inc. (GILD.MI)

– >98% of Treatment-Na?ve Patients Achieved and Maintained Undetectable Viral Load with Biktarvy Through Four Years in the Open-Label Extension Phase of Two Phase 3 Studies... | March 6, 2021

The results were from Ridgeback’s trial to evaluate the treatment’s safety, tolerability, and efficacy to eliminate SARS-CoV-2, the companies said in a joint statement

The antiviral reduced infectious virus in Covid-19 patients in a mid-stage study

By Betsy McKay An experimental Covid-19 drug that promises to be a kind of Tamiflu for the pandemic had positive results in a preliminary study, one of the drug's developers said. The... | March 6, 2021

The antiviral reduced infectious virus in Covid-19 patients in a mid-stage study. Larger trials are under way exploring whether it prevents severe illness and death.

The record-setting development of multiple Covid-19 vaccines will go down in history as some of medical science's greatest achievements. In less than a year, the competing vaccines went from the drawing board to saving lives around the world.

Every now and then, a new trend emerges in the stock market that takes investors by surprise in a very profound way. Whether it was the first kidney transplant ...

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 4) ...

The Most Popular Guru Buys of the 4th Quarter, Stocks: FCX,GILD,SHOP,FISV,SQ, release date:Mar 04, 2021

The Most Popular Guru Buys of the 4th Quarter, Stocks: FCX,GILD,SHOP,FISV,SQ, release date:Mar 04, 2021

Gilead Sciences, Inc. (NASDAQ:GILD) Cowen 41st Annual Health Care Conference March 04, 2021 12:10 PM ET Company Participants Johanna Mercier - Chief Commercial Officer Andrew Dickinson -...

The National Institutes of Health said Thursday that it is putting three more investigational COVID-19 treatments into Phase 2/3 clinical trials. The...

The U.S. death toll from the coronavirus-borne illness COVID-19 climbed above 518,000 on Thursday, as President Joe Biden added his voice to a chorus of...

Shares of Vir Biotechnology Inc. undefined tumbled 5.4% in premarket trading on Thursday, the day after the company said the experimental COVID-19 treatment...

Covina CA, March 02, 2021 (GLOBE NEWSWIRE) -- Global Oral Solid Dosage Excipients Market accounted for US$ 2.8 billion in 2020 and is estimated to be US$ ...

Vancouver, British Columbia, March 01, 2021 (GLOBE NEWSWIRE) -- The global immunotherapy drugs market is projected to reach value of USD 365.57 Billion by ...

Most Food and Drug Administration decisions scheduled for February were positive, and more importantly five new molecular entities passed FDA must...

Most Food and Drug Administration decisions scheduled for February were positive, and more importantly five new molecular entities passed FDA muster. NME ...

Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and fast, with a skew ...